International Companies

Eli Lilly smashes Q1 forecasts as Mounjaro, Zepbound demand soars

By Benjamin Chiou

Date: Thursday 30 Apr 2026

(Sharecast News) - Eli Lilly & Co shares surged on Wall Street on Thursday after the pharma giant smashed market forecasts with its first-quarter results and upped its full-year guidance, helped by soaring demand for its weight-loss treatments.
The Indiana-based firm, which does business as Lilly, reported a 56% jump in...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page